23 results on '"Benucci,Maurizio"'
Search Results
2. Biomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage
3. Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
4. Biosimilars for the treatment of psoriatic arthritis
5. Non-medical switching: save today and pay tomorrow
6. Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2–Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead Immunoassays
7. The Laboratory Role in anti-TNF Biological Therapy Era
8. Abatacept: from a budget impact model to cost-effectiveness analysis – data from RCT and real life
9. Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables
10. Focus on biosimilar etanercept – bioequivalence and interchangeability
11. Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
12. Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
13. Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review
14. Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
15. What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis?
16. Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
17. Costs associated with rheumatoid arthritis in Italy: past, present, and future
18. Drug usage analysis and health care resources consumption in naïve patients with rheumatoid arthritis
19. Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
20. A review of cost–effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis
21. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis
22. Infections during treatment with biological agents and possible treatment in clinical practice
23. Disease activity and antinucleosome antibodies in systemic lupus erythematosus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.